Praxis Precision Medicines, Inc. PRAX Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingActivitiesCashFlowStatement.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s other working capital?
- Praxis Precision Medicines, Inc. (PRAX) reported other working capital of $0 in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s other working capital changed year-over-year?
- Praxis Precision Medicines, Inc.'s other working capital increased by 100.0% year-over-year, from -$2K to $0.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s other working capital?
- Over 3 years (2021 to 2025), Praxis Precision Medicines, Inc.'s other working capital has grown at a -100.0% compound annual growth rate (CAGR), from -$41K to $0.
- What does other working capital mean?
- Net change in working capital items not separately classified — a residual balancing item.